Executive Summary

Oct 2019
PROSPECTS
Value-priced positioning of generics driving sales of these products

Although loyalty towards long-established consumer health brands, especially OTC products, remains relatively high among Argentinians, there has been a noticeable shift towards more affordable generic products. This trend was fuelled by multiple factors, including the economic crisis, low entry barriers, a lack of supervision from the National Administration of Medicine, Nutrition and Medical Technology (ANMAT) and a series of initiatives, mostly from domestic generics manufacturers, to communicate bioequivalence to consumers.

Adult acetaminophen benefiting from Genomma’s investments

Adult acetaminophen is increasing at above-average current value growth rates in overall analgesics due to strong investment in advertising and promotion by Genomma Laboratories Argentina in its Tafirol and Next brands, enabling the group to increase its overall share in analgesics.

Topical analgesics continues to be slightly more dynamic than systemic analgesics

Although there is not a lot in it, topical analgesics continued to be more dynamic than systemic analgesics in 2019, with this expected to continue over the forecast period. Topical analgesics are popular in Argentina, especially among sports enthusiasts and the elderly, as they provide direct relief to affected muscle groups or joints.

COMPETITIVE LANDSCAPE
Genomma Laboratories investing in Tafirol Forte and Next and also launches Tafirol Plus

Genomma Laboratories has been investing in high levels of advertising activity with the aim of promoting Tafirol Forte and Next against other systemic analgesics, as well as the introduction of Tafirol Plus in 2018. It was a very good year for Genomma due to the strong investment in advertising the launch of Tafirol Plus, an analgesic in soft capsule format.

Leader Bayer Argentina helps drive sales through downsizing its aspirin packs

Bayer Argentina continued to be the clear leader in analgesics in 2019. It has been present in analgesics in Argentina for a long time and offers a wide range of products under its brands like Bayaspirina, Bayaspirina C, Bayaspirina Forte, Cafiaspirina and Cafiaspirina Plus.

Players moving towards stronger doses of ibuprofen, aspirin and paracetamol

Some of the main companies in analgesics are looking to promote higher doses of ibuprofen, aspirin and paracetamol in their current lines. One key example of this is Bayer’s Actron 400mg and Actron 600mg, with the 600mg version now accounting for 80% of sales and the 400mg version 20% of sales.

Want to find out more about this report?
Request more information
Why buy this report?

Gain competitive intelligence about market leaders. Track key industry trends, opportunities and threats. Inform your marketing, brand, strategy and market development, sales and supply functions.

Your Recently Viewed Reports

Analgesics in Argentina

Samples (FAQs about samples):

Delivery: Files are delivered directly into your account within a few minutes of purchase.

Overview

Discover the latest market trends and uncover sources of future market growth for the Analgesics industry in Argentina with research from Euromonitor's team of in-country analysts.

Find hidden opportunities in the most current research data available, understand competitive threats with our detailed market analysis, and plan your corporate strategy with our expert qualitative analysis and growth projections.

If you're in the Analgesics industry in Argentina, our research will save you time and money while empowering you to make informed, profitable decisions.

The Analgesics in Argentina market research report includes:

  • Analysis of key supply-side and demand trends
  • Detailed segmentation of international and local products
  • Historic volumes and values, company and brand market shares
  • Five year forecasts of market trends and market growth
  • Robust and transparent market research methodology, conducted in-country

Our market research reports answer questions such as:

  • What is the market size of Analgesics in Argentina?
  • What are the major brands in Argentina?
  • Are combination products with acetaminophen still popular?

Why buy this report?

  • Gain competitive intelligence about market leaders
  • Track key industry trends, opportunities and threats
  • Inform your marketing, brand, strategy and market development, sales and supply functions

This industry report originates from Passport, our Consumer Health market research database.

Analgesics in Argentina - Category analysis

HEADLINES

PROSPECTS

Value-priced positioning of generics driving sales of these products
Adult acetaminophen benefiting from Genomma’s investments
Topical analgesics continues to be slightly more dynamic than systemic analgesics

COMPETITIVE LANDSCAPE

Genomma Laboratories investing in Tafirol Forte and Next and also launches Tafirol Plus
Leader Bayer Argentina helps drive sales through downsizing its aspirin packs
Players moving towards stronger doses of ibuprofen, aspirin and paracetamol

CATEGORY DATA

Table 1 Sales of Analgesics by Category: Value 2014-2019
Table 2 Sales of Analgesics by Category: % Value Growth 2014-2019
Table 3 NBO Company Shares of Analgesics: % Value 2015-2019
Table 4 LBN Brand Shares of Analgesics: % Value 2016-2019
Table 5 Forecast Sales of Analgesics by Category: Value 2019-2024
Table 6 Forecast Sales of Analgesics by Category: % Value Growth 2019-2024

Consumer Health in Argentina - Industry Overview

EXECUTIVE SUMMARY

Consumer health still growing, but at slower rates in 2019
Consumer health expenditure continues increasing
No change at the top, as Bayer, Arcor and Abbott continue to lead
Direct selling performing well against the backdrop of high inflation rates
Further growth expected in consumer health over the forecast period

MARKET INDICATORS

Table 7 Consumer Expenditure on Health Goods and Medical Services: Value 2014-2019
Table 8 Life Expectancy at Birth 2014-2019

MARKET DATA

Table 9 Sales of Consumer Health by Category: Value 2014-2019
Table 10 Sales of Consumer Health by Category: % Value Growth 2014-2019
Table 11 NBO Company Shares of Consumer Health: % Value 2015-2019
Table 12 LBN Brand Shares of Consumer Health: % Value 2016-2019
Table 13 Distribution of Consumer Health by Format: % Value 2014-2019
Table 14 Distribution of Consumer Health by Format and Category: % Value 2019
Table 15 Forecast Sales of Consumer Health by Category: Value 2019-2024
Table 16 Forecast Sales of Consumer Health by Category: % Value Growth 2019-2024

APPENDIX

OTC registration and classification
Vitamins and dietary supplements registration and classification
Self-medication/self-care and preventive medicine
Switches

DEFINITIONS

SOURCES

Summary 1 Research Sources